Dr. Roger Dulos, MD
Claim this profileSt. Paul's Hospital
Studies Nephritis
Studies Lupus Nephritis
1 reported clinical trial
1 drug studied
Area of expertise
1Nephritis
Antinuclear antibodies (ANA)
Anti-dsDNA antibodies
Anti-Smith antibodies
2Lupus Nephritis
Antinuclear antibodies (ANA)
Anti-dsDNA antibodies
Anti-Smith antibodies
More about Roger Dulos, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Roger Dulos, MD has experience with
- Daxdilimab
Breakdown of trials Roger Dulos, MD has run
Nephritis
Lupus Nephritis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Roger Dulos, MD specialize in?
Roger Dulos, MD focuses on Nephritis and Lupus Nephritis. In particular, much of their work with Nephritis has involved Antinuclear antibodies (ANA) patients, or patients who are Anti-dsDNA antibodies.
Is Roger Dulos, MD currently recruiting for clinical trials?
No, Roger Dulos, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Roger Dulos, MD has studied deeply?
Yes, Roger Dulos, MD has studied treatments such as Daxdilimab.
What is the best way to schedule an appointment with Roger Dulos, MD?
Apply for one of the trials that Roger Dulos, MD is conducting.
What is the office address of Roger Dulos, MD?
The office of Roger Dulos, MD is located at: St. Paul's Hospital, Iloilo City, Iloilo 5000 Philippines. This is the address for their practice at the St. Paul's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.